Seroquel XR 300 mg tablete s produljenim oslobađanjem
Name | Seroquel XR 300 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-408184728 |
Active Substance | quetiapinum |
Pharmaceutical Form | tableta s produljenim oslobađanjem |
Strength | 300 mg |
Packaging [MA Number for Packaging] | 10 tableta u blisteru, u kutiji [HR-H-408184728-01] 30 tableta u blisteru, u kutiji [HR-H-408184728-02] 50 tableta u blisteru, u kutiji [HR-H-408184728-03] 60 tableta u blisteru, u kutiji [HR-H-408184728-04] 100 tableta u blisteru, u kutiji [HR-H-408184728-05] |
Manufacturer | AstraZeneca UK Limited, Macclesfield, Cheshire, Ujedinjeno Kraljevstvo AstraZeneca GmbH, Wedel, Njemačka |
Marketing Authorisation Holder | AstraZeneca d.o.o., Radnička cesta 80, Zagreb, Hrvatska |
Marketing Authorisation Date | 20.04.2016 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/15-02/71 |
Registration Number | 381-12-01/70-16-07 |
Composition | jedna tableta s produljenim oslobađanjem sadrži 300 mg kvetiapina (u obliku kvetiapinfumarata) |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N05AH04 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2 |